Substance abuse and cerebral blood flow
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE AND METHOD: This paper reviews acute and chronic effects of drugs of abuse on cerebral blood flow (CBF) and metabolism and their clinical significance. The most important source of information for the review is human research reports published in refereed journals. A few animal studies, book chapters, and abstracts that are especially relevant are also included. RESULTS: In humans, ethanol in small doses produces cerebral vasodilation; higher doses induce cerebral vasoconstriction. Chronic alcoholism is associated with reduced CBF and cerebral metabolism. Sedatives and antianxiety drugs lead to global reduction in CBF and cerebral metabolism. Caffeine, even in small doses, is a potent cerebral vasoconstrictor. Cerebral vasodilation is seen immediately after cigarette smoking, but chronic smokers show global reduction in CBF. Changes in CBF after marijuana smoking are variable; both increases and decreases are seen. Chronic marijuana smoking, however, seems to reduce CBF. Most inhalants and solvents are vasodilators; chronic abuse is accompanied by a decrease in CBF. A number of drugs of abuse, including ethanol, amphetamines, cocaine, nicotine, and caffeine-phenylpropanolamine combinations, increase the risk for stroke. Reduction in CBF associated with chronic use of ethanol, nicotine, inhalants, and solvents is at least partially reversible upon abstinence. CONCLUSIONS: Topics for future research include regional brain function, which mediates drug-induced mood changes (euphoria); CBF concomitants of psychological and physiological characteristics that increase addiction potential; changes in CBF that accompany withdrawal syndromes; mechanisms responsible for drug-induced stroke; and effects of functional and organic complications on CBF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Korsten, M. A., Matsuzaki, S., Feinman, L., & Lieber, C. S. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920802 · Cited by 518
Caffeine induced changes in cerebral circulation.
Mathew, R. J., & Wilson, W. H. (1985) · Stroke · doi:10.1161/01.str.16.5.814 · Cited by 142
Self-citationWolkin, A., Angrist, B., Wolf, A., Brodie, J., Wolkin, B., Jaeger, J., Cancro, R., & Rotrosen, J. (1987) · Psychopharmacology · doi:10.1007/bf00177923 · Cited by 100
Caffeine Consumption, Withdrawal and Cerebral Blood Flow
Mathew, R. J., & Wilson, W. H. (1985) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1985.hed2506305.x · Cited by 55
Self-citation
Cited by
Smoking-Induced Ventral Striatum Dopamine Release
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1211 · Cited by 347
LUNDQVIST, T. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.017 · Cited by 331
Cardiovascular System Effects of Marijuana
Jones, R. T. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06004.x · Cited by 319
"Loss of control" in alcoholism and drug addiction: A neuroscientific interpretation.
Lyvers, M. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.2.225 · Cited by 311
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
Hietala, J., West, C., Syvälahti, E., Någren, K., Lehikoinen, P., Sonninen, P., & Ruotsalainen, U. (1994) · Psychopharmacology · doi:10.1007/bf02245330 · Cited by 269
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1991-03-01
- Volume
- 148
- Issue
- 3
- Pages
- 292-305
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W116205265
- Cited by
- 148
- References
- 5
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.